Stopping dupilumab when asthma is well controlled
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests whether it’s safe to stop taking dupilumab once your severe asthma has been well controlled for a long time. If you join, you may stop the medication and be closely monitored to see if your asthma stays under control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been on dupilumab for at least 3 years for severe asthma.
- Your asthma is well controlled — you use your rescue inhaler rarely and have had 0 or 1 asthma attack in the last year.
- Your breathing test (FEV1) is greater than 30% of the predicted value.
- You are not on high-dose oral steroids (10 mg or more of prednisone per day), you are not pregnant or breastfeeding, and you do not smoke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to monitor severe asthma that is driven by high levels of inflammation (T2-high). It involves a bronchoscopy (a thin tube to look inside your lungs) to see how well the treatment is working.
This trial tests whether dupilumab, a medicine that helps reduce airway inflammation, can help people with asthma achieve remission. You may be eligible if you have asthma with high markers of inflammation and have had asthma attacks despite using your regular inhaler.
This study looks at how well and how safely the medicine Dupilumab works for children whose asthma is not well-controlled with their current inhalers. The goal is to see if it can help reduce asthma attacks and improve daily life.
This study tests whether dupilumab improves how well mucus is cleared from the airways in adults with moderate to severe asthma. It may help find better ways to reduce mucus-related breathing problems in people with a specific asthma type.
This study looks at whether children with well-controlled eczema can safely reduce how often they take Dupixent. It aims to find the lowest effective dose to keep eczema under control.
This study looks at how well dupilumab works for people with uncontrolled COPD who have high levels of a certain white blood cell (eosinophils). It collects information from routine doctor visits to see how patients feel and if the treatment is safe.
Hear when a new Severe Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.